定制减重支架与常规食管支架治疗袖状胃切除术后漏的对比:系统评价与比例Meta分析
该系统评价与比例Meta分析比较了定制减重支架(CBS)与常规食管支架(CES)治疗袖状胃切除术后漏(SGL)的疗效与安全性。CBS的技术成功率为99%(93-100%),临床成功率为82%(69-93%),支架移位率为32%(17-49%);CES分别为100%(97-100%)、93%(85-98%)和15%(7-25%)。CBS临床成功率较低(差11%)、移位率较高(差17%),但成功治疗患者中CBS所需支架数和内镜次数更少、漏闭合时间更短;证据质量极低。
要点
- CES临床成功率93%高于CBS的82%,移位率15%低于CBS的32%。
- CBS成功治疗者所需支架数和内镜次数更少,漏闭合时间更短。
- 总体证据质量极低,CBS设计仍需改进以提升结局。
核心结论
- 极低水平证据表明CES在临床成功率和移位率上优于CBS,但CBS可能减少支架置入和内镜操作次数。
研究设计与样本
- 系统检索PubMed、Cochrane Library、Scopus、Web of Science和Google Scholar至2020年5月1日,采用随机效应模型进行比例Meta分析。
主要发现
- CBS技术成功率99%(93-100%),临床成功率82%(69-93%),支架移位率32%(17-49%)。
- CES技术成功率100%(97-100%),临床成功率93%(85-98%),支架移位率15%(7-25%)。
- 两种支架非移位不良事件均极低。
- 比例差异显示CBS临床成功率低11%、移位率高17%。
- 成功治疗患者中CBS平均支架数和内镜次数更少,漏闭合时间更短。
临床怎么用
- CES在临床成功率和移位率方面表现更优,但CBS可能减少操作次数和漏闭合时间。
- 证据质量极低,选择支架类型需结合患者具体情况并期待支架设计改进。
局限性
- 总体证据质量极低。
- 证据仍非常不确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Recently, there has been a burgeoning interest in the utilization of customized bariatric stents (CBS) for management of sleeve gastrectomy leak (SGL). We aimed to conduct a proportion meta-analysis to evaluate the cumulative efficacy and safety of these new stents and to compare them with the conventional esophageal stents (CES). METHODS: A systematic literature search of the PubMed, Cochrane Library, Scopus, Web of Science and Google Scholar databases was conducted through May 1, 2020. Primary outcomes were technical and clinical success and post-procedure adverse events of CBS and CES. Secondary outcomes were number of stents and endoscopic sessions per patient, and time to leak closure. A proportion meta-analysis was performed on outcomes using a random-effects model, and the weighted pooled rates (WPRs) or mean difference with 95% confidence interval (CI) were calculated. RESULTS: The WPR with 95% CI of technical success, clinical success, and stent migration for CBS were 99% (93-100%) I2 = 34%, 82% (69-93%) I2 = 58%, and 32% (17-49%), I2 = 69%, respectively. For CES, the WPR (95% CI) for technical success, clinical success, and stent migration were 100% (97-100%) I2 = 19%, 93% (85-98%) I2 = 30%, and 15% (7-25%), I2 = 41%, respectively. Adverse events other than migration were very low with both types of stents. On proportionate difference, CBS had lower clinical success (11%) and higher migration rate (17%) in comparison to CES. In successfully treated patients, CBS was associated with lower mean number of stents and endoscopic sessions, and shorter time to leak closure compared to CES. The overall quality of evidence was very low. CONCLUSIONS: In treatment of SGL, there is very low level evidence that CES are superior to CBS in terms of clinical success and migration rate, though may require more stent insertions and endoscopic procedures. The evidence however remains very uncertain. Perhaps relevant to some types of stents, CBS are promising; however design modification is strongly recommended to improve outcomes.
引用
- Hamid HKS, Emile SH, Saber AA, et al. Customized bariatric stents for sleeve gastrectomy leak: are they superior to conventional esophageal stents? A systematic review and proportion meta-analysis. Surg Endosc. 2020. PMID: 33159298. doi:10.1007/s00464-020-08147-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。